DE3784907T2 - Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe. - Google Patents

Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe.

Info

Publication number
DE3784907T2
DE3784907T2 DE8787202625T DE3784907T DE3784907T2 DE 3784907 T2 DE3784907 T2 DE 3784907T2 DE 8787202625 T DE8787202625 T DE 8787202625T DE 3784907 T DE3784907 T DE 3784907T DE 3784907 T2 DE3784907 T2 DE 3784907T2
Authority
DE
Germany
Prior art keywords
oligosaccharides
vaccines
immunogens
immunogenes
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787202625T
Other languages
English (en)
Other versions
DE3784907D1 (de
Inventor
Eduard Coen Beuvery
Adolf Evenberg
Jan Theunis Poolman
Boom Jacobus Hubertus Van
Peter Hoogerhout
Boeckel Constant Adriaan A Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlanden Staat
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Application granted granted Critical
Publication of DE3784907D1 publication Critical patent/DE3784907D1/de
Publication of DE3784907T2 publication Critical patent/DE3784907T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
DE8787202625T 1986-12-31 1987-12-28 Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe. Expired - Fee Related DE3784907T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8603325 1986-12-31

Publications (2)

Publication Number Publication Date
DE3784907D1 DE3784907D1 (de) 1993-04-22
DE3784907T2 true DE3784907T2 (de) 1993-06-24

Family

ID=19849078

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787202625T Expired - Fee Related DE3784907T2 (de) 1986-12-31 1987-12-28 Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe.

Country Status (15)

Country Link
US (1) US5034519A (de)
EP (1) EP0276516B1 (de)
JP (1) JPS63190896A (de)
KR (1) KR880007557A (de)
AT (1) ATE87003T1 (de)
AU (1) AU603405B2 (de)
CA (1) CA1335405C (de)
DE (1) DE3784907T2 (de)
DK (1) DK694687A (de)
ES (1) ES2054657T3 (de)
FI (1) FI89172C (de)
IE (1) IE59734B1 (de)
NO (1) NO169775C (de)
NZ (1) NZ223009A (de)
PT (1) PT86484B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320942A3 (de) * 1987-12-18 1989-10-04 American Cyanamid Company Polysaccharide und makromolekulare Verbindungen davon
EP0338265B1 (de) * 1988-04-19 1994-05-04 American Cyanamid Company Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
EP0378929A3 (de) * 1988-12-23 1990-08-01 Connaught Laboratories Limited Membran-Proteine und Peptide von Haemophilus influenzae Typ B
GB8924473D0 (en) * 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
WO1992010936A1 (en) * 1990-12-21 1992-07-09 Microcarb, Inc. ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5409705A (en) * 1991-05-20 1995-04-25 Kao Corporation Phosphobetaine and detergent and cosmetic containing the same
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
DE122007000101I1 (de) * 1992-06-25 2008-03-27 Papillomavirus vakzine
US7148031B2 (en) 1994-07-26 2006-12-12 The Mitre Corporation Sequestering of glycoprotein molecules and oligosaccharide moieties in lipo-glycoprotein membranes and micelles
US5762256A (en) 1995-08-28 1998-06-09 United States Surgical Corporation Surgical stapler
US5782396A (en) 1995-08-28 1998-07-21 United States Surgical Corporation Surgical stapler
US6032849A (en) * 1995-08-28 2000-03-07 United States Surgical Surgical stapler
SE9601158D0 (sv) * 1996-03-26 1996-03-26 Stefan Svenson Method of producing immunogenic products and vaccines
CA2264735C (en) * 1996-08-27 2008-01-29 Chiron Corporation Neisseria meningitidis serogroup b glycoconjugates and methods of using the same
US6267961B1 (en) * 1996-11-22 2001-07-31 Baxter International Inc. Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
CU22904A1 (es) * 1999-08-30 2004-01-23 Univ De Ottawa Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
US8785134B2 (en) 2008-11-10 2014-07-22 The Mitre Corporation Glycoprotein vesicles and their methods of use
JP6784841B2 (ja) 2016-07-28 2020-11-11 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー ヘモフィルス属インフルエンザ菌ｂ型に対するワクチンとしての安定した加水分解耐性合成ポリリボシルリビトールホスフェート誘導体
CN108776223B (zh) * 2018-04-19 2021-04-06 广州质量监督检测研究院 紫外吸收剂uv-326检测试剂盒及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine

Also Published As

Publication number Publication date
PT86484A (en) 1988-01-01
CA1335405C (en) 1995-04-25
DK694687D0 (da) 1987-12-30
NO875442L (no) 1988-07-01
NO875442D0 (no) 1987-12-28
IE59734B1 (en) 1994-03-23
PT86484B (pt) 1990-11-20
NZ223009A (en) 1990-06-26
DK694687A (da) 1988-07-01
JPS63190896A (ja) 1988-08-08
KR880007557A (ko) 1988-08-27
FI875727A (fi) 1988-07-01
ES2054657T3 (es) 1994-08-16
IE873510L (en) 1988-06-30
FI875727A0 (fi) 1987-12-28
AU603405B2 (en) 1990-11-15
FI89172B (fi) 1993-05-14
DE3784907D1 (de) 1993-04-22
FI89172C (fi) 1993-08-25
NO169775C (no) 1992-08-05
EP0276516A3 (en) 1988-08-17
ATE87003T1 (de) 1993-04-15
US5034519A (en) 1991-07-23
AU8314587A (en) 1988-07-07
NO169775B (no) 1992-04-27
EP0276516A2 (de) 1988-08-03
EP0276516B1 (de) 1993-03-17

Similar Documents

Publication Publication Date Title
DE3784907D1 (de) Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe.
DE69112463T2 (de) Vorrichtung zur Herstellung von Monokristallen nach dem Czochralski-Verfahren.
DE69107264T2 (de) Verfahren zur Herstellung von höhere Alkoxygruppe enthaltenden Polysiloxanen.
DE3750176T2 (de) Impfstoff und verfahren zur herstellung.
DE3784123D1 (de) Verfahren zur herstellung keramischer verbundwerkstoffe.
DE3772423D1 (de) Verfahren zur herstellung von makrolidderivaten.
DE3887442T2 (de) Verfahren zur Herstellung von Polysiloxanen mit endständigen Hydroxylgruppen.
DE68915915T2 (de) Verfahren zur Herstellung von cyclischen Polysiloxanen.
DE3868176D1 (de) Verfahren zur herstellung von siliciumtetrachlorid.
DE3674379D1 (de) Verfahren zur herstellung von perfluorcarbonsaeuren.
DE68923915D1 (de) Verfahren zur Herstellung cyclischer Arylchlorophosphite.
DE69020628D1 (de) Verfahren zur Herstellung arylterminierter Organosiloxane.
DE3776494D1 (de) Verfahren zur herstellung von 4,4'-dihydroxybiphenyl.
ATE21033T1 (de) Verfahren zur herstellung eines immunogens aus pasteurella multocida.
DE58909397D1 (de) Verfahren zur Herstellung von 4-Hydroxy-1,2,2,6,6-pentamethylpiperidin.
DE3768617D1 (de) Verfahren zur herstellung von 2,4-diamino-3-oxy-pyrimidin-derivaten.
PT85365A (de) Verfahren zur herstellung von 1,4-dihydropyridin-3-carbonsaurephenoxyaliphatyphenylenoxyalkylester
DE3761569D1 (de) Verfahren zur herstellung zyklischer halbacetale.
DE59000644D1 (de) Verfahren zur herstellung von kondensmilch.
DE3875885T2 (de) Methode zur herstellung von polycyclischen 1,3-thiazolidinen.
DE3761905D1 (de) Verfahren zur herstellung von 9(11)-dehydroandrostanen.
ATA63891A (de) Verfahren zur herstellung von (2,5-dihydro-2-oxo- 5-phenyl-3-furanyl)aminen
DD138329A1 (de) Verfahren zur herstellung von tetanus-impfstoffen
ATE78256T1 (de) Verfahren zur herstellung von makrolid-derivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee